With companies such as the Stratified Medicine Scotland Innovation Centre (SMS-IC) who focus on Scotland’s place in Precision Medicine, as well as top medical universities such as Glasgow University and its research within the Queen Elizabeth University Hospital, Scotland hopes to be the leading voice in using big data to influence the future of medical research.
From statins to anti-depressants, oncology and asthma, the vast amount of medical data available in Scotland is being used to research precision medicine in order to specifically target patient’s genetic makeup rather than produce pharmaceutical drugs for the entire population.
